GSK

GSK’s Exdensur (depemokimab) Secures Japanese Regulatory Green Light For Severe Asthma & Chronic Rhinosinusitis Treatment

GSK’s Exdensur (depemokimab) Secures Japanese Regulatory Green Light For Severe Asthma & Chronic Rhinosinusitis Treatment

07 Jan 2026

2 min read

Samsung Biologics Expands U.S. Footprint With $280M Maryland Drug Manufacturing Buy

Samsung Biologics Expands U.S. Footprint With $280M Maryland Drug Manufacturing Buy

23 Dec 2025

1 min read

GSK Signs US Government Deal To Reduce Prices And Boost Access To Respiratory Drugs

GSK Signs US Government Deal To Reduce Prices And Boost Access To Respiratory Drugs

22 Dec 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com